Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. (Q51325737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

1 reference

1 reference

coronary artery disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Paul Welsh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Naveed Sattar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

John McMurray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rury Holman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Suzanne M Lloyd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ian Ford

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Miles Fisher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Chris J Packard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

7 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

116-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Obesity, Metabolic Syndrome, and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Impaired fasting glucose and impaired glucose tolerance: implications for care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Mannheim intima-media thickness consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970152-9

7 January 2021

10.1016/S2213-8587(13)70152-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24622715%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference